List of works - Grzegorz Porebski

A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency

scientific article published on 17 January 2020

Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper

scientific article published on 5 March 2022

Allergy workup of severe cutaneous adverse drug reactions: a light at the end of the tunnel?

scientific article

Alpha-gal syndrome: the first report in Poland

scientific article published in 2021

Biomarkers in Hereditary Angioedema

scientific article published in June 2021

Clinical Characteristics and Management of Angioedema Attacks in Polish Adult Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency

scientific article published on 29 November 2021

Common allergies do not influence the prevalence of cutaneous hypersensitivity reactions to antiepileptic drugs

scientific article published on 17 May 2017

Cytotoxic diagnostic assays are effective in drug-induced maculopapular exanthemas

scientific article published on 11 March 2015

Cytotoxic‑based assays in delayed drug hypersensitivity reactions induced by antiepileptic drugs

scientific article published on 08 September 2015

Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor

scientific article published on 23 October 2020

Drug-specific in vitro release of IFN-gamma in patients with delayed cutaneuos drug hypersensitivity reactions.

scientific article published on 11 March 2015

Drug-specific in vitro secretion of IFNγ in the diagnosis of drug-induced exanthemas: electrochemiluminescence assay versus previously used diagnostic methods

scientific article published on January 2015

ELISpot assay as a diagnostic tool in drug hypersensitivity reactions

scientific article published in August 2021

Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007⁻2018

scientific article published on 17 January 2019

In Vitro Assays in Severe Cutaneous Adverse Drug Reactions: Are They Still Research Tools or Diagnostic Tests Already?

scientific article published on 10 August 2017

In vitro diagnosis of T cell-mediated drug allergy.

scientific article published on 22 February 2011

In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test

scientific article

Inhalation challenges with agents in diagnosis of occupational asthma

scientific article published in January 2002

Life-threatening laryngeal attacks in hereditary angioedema patients

scientific article published on 01 March 2020

Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions

Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema

scientific article published on 18 May 2021

Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.

scientific article published on 8 March 2016

Residential proximity to major roadways is associated with increased prevalence of allergic respiratory symptoms in children

scientific article published on January 2014

Risk Factors for Hepatotoxicity Due to Paracetamol Overdose in Adults

scientific article published on 25 July 2021

Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy

scientific article published on 03 June 2019

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)

scientific article published on 07 July 2022

Secretory leukocyte protease inhibitor regulates nerve reflex‐mediated skin barrier function in psoriasis

scientific article published on 5 April 2022

Serum albumin complexation of acetylsalicylic acid metabolites

scientific article published in June 2009

Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency

scientific article published on 16 May 2018

The clinical use of serum Mas-Related G Protein-Coupled Receptor-X2 as a diagnostic biomarker is questionable

scientific article published on 29 June 2021

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

scientific article published on 3 February 2022

The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?

scientific article published on 01 September 2013

[Basophil activation test--a practical approach to diagnosis of common respiratory allergy]

scientific article published in January 2015

[Desensitization in drug hypersensitivity]

scientific article published in January 2013

[Exercise-induced asthma and anaphylaxis]

scientific article published on 01 January 2002

[Irrational use of drugs as a source of drug - induced diseases]

scientific article published on 01 April 2007

[Pharmacogenomics of severe drug hypersensitivity reactions--from bench to bedside]

scientific article published in January 2015

[Prevalence of drug allergy claims in school children]

scientific article published in January 2015

[Recent advances in the in vitro diagnosis of drug allergy]

[Recombinant human C1-inhibitor is effective in the treatment of acute attacks of hereditary angioedema--case report]

scientific article published on 01 January 2005

List of works by Grzegorz Porebski

A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency

Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper

Allergy workup of severe cutaneous adverse drug reactions: a light at the end of the tunnel?

Alpha-gal syndrome: the first report in Poland

Biomarkers in Hereditary Angioedema

Clinical Characteristics and Management of Angioedema Attacks in Polish Adult Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency

Common allergies do not influence the prevalence of cutaneous hypersensitivity reactions to antiepileptic drugs

Cytotoxic diagnostic assays are effective in drug-induced maculopapular exanthemas

Cytotoxic‑based assays in delayed drug hypersensitivity reactions induced by antiepileptic drugs

Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor

Drug-specific in vitro release of IFN-gamma in patients with delayed cutaneuos drug hypersensitivity reactions.

Drug-specific in vitro secretion of IFNγ in the diagnosis of drug-induced exanthemas: electrochemiluminescence assay versus previously used diagnostic methods

ELISpot assay as a diagnostic tool in drug hypersensitivity reactions

Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007⁻2018

In Vitro Assays in Severe Cutaneous Adverse Drug Reactions: Are They Still Research Tools or Diagnostic Tests Already?

In vitro diagnosis of T cell-mediated drug allergy.

In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test

Inhalation challenges with agents in diagnosis of occupational asthma

Life-threatening laryngeal attacks in hereditary angioedema patients

Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions

Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema

Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.

Residential proximity to major roadways is associated with increased prevalence of allergic respiratory symptoms in children

Risk Factors for Hepatotoxicity Due to Paracetamol Overdose in Adults

Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)

Secretory leukocyte protease inhibitor regulates nerve reflex‐mediated skin barrier function in psoriasis

Serum albumin complexation of acetylsalicylic acid metabolites

Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency

The clinical use of serum Mas-Related G Protein-Coupled Receptor-X2 as a diagnostic biomarker is questionable

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?

[Basophil activation test--a practical approach to diagnosis of common respiratory allergy]

[Desensitization in drug hypersensitivity]

[Exercise-induced asthma and anaphylaxis]

[Irrational use of drugs as a source of drug - induced diseases]

[Pharmacogenomics of severe drug hypersensitivity reactions--from bench to bedside]

[Prevalence of drug allergy claims in school children]

[Recent advances in the in vitro diagnosis of drug allergy]

[Recombinant human C1-inhibitor is effective in the treatment of acute attacks of hereditary angioedema--case report]

[The benefits of using basophil activation test as a diagnostic tool prior to specific immunotherapy with inhalant allergens]